Evidence map›Paper›PMID 12853306›Full record

ReviewAnnals of the New York Academy of Sciences2003

N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons.

Xueying Jiang, Daming Zhu, Peter Okagaki, Robert Lipsky, Xuan Wu, Krishna Banaudha, Karen Mearow, Kenneth I Strauss, Ann M Marini

Open access · bronzeAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effects ofFrontiers in nutrition · 2022
    Article
  7. Article
  8. Genome instability in Alzheimer disease.Mechanisms of ageing and development · 2017
    Review
  9. Review
  10. Article
  11. Review
  12. Increased BDNF protein expression after ischemic or PKC epsilon preconditioning promotes electrophysiologic changes that lead to neuroprotection.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xueying JiangDepartment of Neurology and Neuroscience, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.
Daming Zhu
Peter Okagaki
Robert Lipsky
Xuan Wu
Krishna Banaudha
Karen Mearow
Kenneth I Strauss
Ann M Marini
Uniformed Services University of the Health Sciences · USMemorial University of Newfoundland · CANational Institutes of Health · US

Funding

ABERRANT REGULATION OF COX2 AFTER TRAUMATIC BRAIN INJURYR01NS038654 · NINDS · UNIVERSITY OF CINCINNATI · PI STRAUSS, KENNETH I · 2000 to 2003
$1.1M
NINDS NIH HHS R01 NS038654
6 · The paper itself

Abstract

Delineating the mechanisms of survival pathways that exist in neurons will provide important insight into how neurons utilize intracellular proteins as neuroprotectants against the causes of acute neurodegeneration. We have employed cultured rat cerebellar granule cells as a model for determining the mechanisms of these intraneuronal survival pathways. Glutamate has long been known to kill neurons by an N-methyl-d-aspartate (NMDA) receptor-mediated mechanism. Paradoxically, subtoxic concentrations of NMDA protect neurons against glutamate-mediated excitotoxicity. Because NMDA protects neurons in physiologic concentrations of glucose and oxygen, we refer to this phenomenon as physiologic preconditioning. One of the major mechanisms of NMDA neuroprotection involves the activation of NMDA receptors leading to the rapid release of brain-derived neurotrophic factor (BDNF). BDNF then binds to and activates its cognate receptor, receptor tyrosine kinase B (TrkB). The efficient utilization of these two receptors confers remarkable resistance against millimolar concentrations of glutamate that kill more than eighty percent of the neurons in the absence of preconditioning the neurons with a subtoxic concentration of NMDA. Exactly how the neurons mediate neuroprotection by activation of both receptors is just beginning to be understood. Both NMDA and TrkB receptors activate nuclear factor kappaB (NF-kappaB), a transcription factor known to be involved in protecting neurons against many different kinds of toxic insults. By converging on survival transcription factors, such as NF-kappaB, NMDA and TrkB receptors protect neurons. Thus, crosstalk between these very different receptors provides a rapid means of neuronal communication to upregulate survival proteins through release and transcriptional activation of messenger RNA.

Indexed as

AnimalsAutocrine CommunicationBrain-Derived Neurotrophic FactorCells, CulturedCerebellumGenes, bcl-2Glutamic AcidIschemic PreconditioningNeuronsNeuroprotective AgentsNF-kappa BN-MethylaspartateOligonucleotides, AntisenseReceptors, N-Methyl-D-AspartateReceptor, trkBBrain-Derived Neurotrophic FactorGlutamic AcidNeuroprotective AgentsNF-kappa BN-MethylaspartateOligonucleotides, AntisenseReceptors, N-Methyl-D-AspartateReceptor, trkB

Identifiers

PMID12853306
PMCPMC2597300
OpenAlexW1209665789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.